Clinical trials
Phase 2 Parkinson Disease trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Integrative Research Laboratories AB | 2 |
| AstraZeneca | 1 |
| Bial R&D Investments, S.A. | 1 |
| Center for Neurology, Stockholm | 1 |
| Genzyme, a Sanofi Company | 1 |
| Neurolixis SAS | 1 |
| Orion Corporation, Orion Pharma | 1 |
| Sanofi | 1 |
| University Hospital Tuebingen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 10 |
| Basal Ganglia Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Dyskinesia, Drug-Induced | 1 |
| Dyskinesias | 1 |
| Movement Disorders | 1 |
| Neurodegenerative Diseases | 1 |
| Parkinsonian Disorders | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.